Search results for "High Pressure"

showing 10 items of 894 documents

UDP-glucosyltransferase activity toward exogenous substrates in Drosophila melanogaster.

1991

To investigate the capacity of Drosophila extracts to glucosylate exogenous substrates we have developed a fast and sensitive method for the detection of UDP-glucosyltransferase activity using 4-nitrophenol, 1-naphthol, or 2-naphthol as substrates. High-performance liquid chromatography was used to separate and quantitate the reaction products, allowing detection of activities that produced as little as 1 pmol of 2-naphthol glucoside (fluorescence detection) or 16 pmol of 4-nitrophenol glucoside (absorbance detection). Optimal activity was found at 43 degrees C and alkaline pH. The affinity of the Drosophila enzyme was 250-fold higher for 1-naphthol or 2-naphthol (Km approximately 4 microM)…

BiophysicsNaphtholsBiochemistryHigh-performance liquid chromatographyUridine DiphosphateSubstrate SpecificityAbsorbanceNitrophenolschemistry.chemical_compoundGlucosideDrosophilidaeAnimalsMolecular BiologyChromatography High Pressure Liquidchemistry.chemical_classificationChromatographybiologySubstrate (chemistry)Cell BiologyHydrogen-Ion Concentrationbiology.organism_classificationFluorescenceEnzymeDrosophila melanogasterchemistryBiochemistryGlucosyltransferasesDrosophila melanogasterAnalytical biochemistry
researchProduct

Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Bisoprolol Fumarate

2014

Abstract Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate-release (IR) solid oral dosage forms containing bisoprolol as the sole active pharmaceutical ingredient (API) are reviewed. Bisoprolol is classified as a Class I API according to the current Biopharmaceutics Classification System (BCS). In addition to the BCS class, its therapeutic index, pharmacokinetic properties, data related to the possibility of excipient interactions, and reported BE/bioavailability problems are taken into consideration. Qualitative compositions of IR tablet dosage forms of bisoprolol with a marketing authorization (MA) in ICH (Inter…

Bisoprolol FumarateCell Membrane PermeabilityAdrenergic beta-AntagonistsBiological AvailabilityPharmaceutical ScienceExcipientPharmacologyBioequivalenceDosage formBiopharmaceuticsExcipientsmedicineBisoprololHumansTissue DistributionBiotransformationChromatography High Pressure LiquidHeart FailureActive ingredientChemistryStereoisomerismHydrogen-Ion ConcentrationBiopharmaceutics Classification SystemBioavailabilityIntestinal AbsorptionSolubilityTherapeutic EquivalencyBisoprololmedicine.drugJournal of Pharmaceutical Sciences
researchProduct

Bis(hydroxyphenyl)methane-bisphenol F-metabolism by the HepG2 human hepatoma cell line and cryopreserved human hepatocytes

2011

author cannot archive publisher's version/PDF; International audience; Bisphenol F (BPF) is present in the environment and as a contaminant of food. Humans may, therefore, be exposed to BPF, and an assessment of this risk is required. BPF has been shown to have genotoxic and endocrine-disruptor properties in a human hepatoma cell line (HepG2), which is a model system for studies of xenobiotic toxicity. In this study, we investigated the ability of HepG2 cells to biotransform BPF, because metabolism may affect the observed effects of BPF, and we compared this metabolic capacity with that of human hepatocytes. Cells were incubated for 24 hours with [(3)H]-BPF. The culture medium was then conc…

Bisphenol FHealth Toxicology and MutagenesisestrogenicityCell Culture Techniques010501 environmental sciencesToxicology01 natural sciencesMass SpectrometryCryopreservationchemistry.chemical_compoundenzyme level[SDV.IDA]Life Sciences [q-bio]/Food engineeringperformance liquid chromatographyratLuciferasesinductionChromatography High Pressure Liquidendocrine disruptor0303 health sciencesfood and environmental contaminantMolecular StructureHep G2 CellsGeneral MedicineBiochemistryHepg2 cellsin vitro modeldispositionToxicityEnvironmental Pollutantsliver enzymebiotransformationGlucuronidePlasmidsBiologyTransfectionliver03 medical and health sciencesHumans[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringBenzhydryl Compounds030304 developmental biology0105 earth and related environmental sciencesCryopreservationPharmacologyChemical Health and Safetyactivitybisphenol aEstrogen Receptor alphaPublic Health Environmental and Occupational HealthMetabolismbeta-GalactosidaseHepatoma cell linechemistryHepatocytesXenobiotic
researchProduct

Adrenic acid Δ4 desaturation and fatty acid composition in the liver of marine-oil fed streptozotocin diabetic rats

1998

The aim of the present study was to assess the effect of streptozotocin diabetes and insulin treatment on adrenic acid delta4 desaturation and fatty acid composition of liver microsomes in Wistar rats fed a fat free semi-synthetic basal diet supplemented with 10% EPA-rich marine oil. Results showed that, in liver microsomes of hyperglycemic rats, the 22:6n-3/22:5n-3 ratio in total lipids was elevated and desaturation of adrenic acid to n-6 docosapentaenoic acid was enhanced. Insulin treatment with 2.0 I.U./100 g body weight-1 twice a day for 3 days resulted in hypoglycemia and suppressed both the increased delta4 n-6 desaturation and 22:6n-3/22:5n-3 ratio. It is concluded that the delta4 de…

Blood GlucoseMaleErucic Acidsmedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryBiologyHypoglycemiaStreptozocinDiabetes Mellitus Experimentalchemistry.chemical_compoundFish OilsDiabetes mellitusInternal medicinemedicineAnimalsInsulinRats WistarChromatography High Pressure LiquidPancreatic hormoneInsulinFatty AcidsCell Biologymedicine.diseaseStreptozotocinLipidsEicosapentaenoic acidRatsEndocrinologyLiverBasal (medicine)chemistryFatty Acids UnsaturatedMicrosomes LiverDocosapentaenoic acidmedicine.drugProstaglandins, Leukotrienes and Essential Fatty Acids
researchProduct

Bone status in adolescents with type 1 diabetes

2010

Aims The aim of the study was to investigate the potential negative impact of type 1 diabetes on bone status of adolescents. Bone status in adolescents with type 1 diabetes was assessed by means of quantitative ultrasound (QUS) and the influence of metabolic control and other diseaserelated and growth variables was analysed. Methods Group I consisted of 99 pubertal (Tanner ≥2) adolescents (49 female), aged 14.3±2.5 years, diabetes duration 4.6±2.3 years. Controls (group II) were 297 children, matched by sex and age, from a healthy population. The influence of glycated haemoglobin (current: HbA1cD; last year’s mean: HbA1cY; whole duration mean: HbA1cT), diabetes duration, percentage of life …

Blood GlucoseMalemedicine.medical_specialtyHbA1cAdolescentEndocrinology Diabetes and Metabolismmedicine.medical_treatmentDiseaseBone and BonesStatistics NonparametricSurveys and QuestionnairesDiabetes mellitusInternal medicineImmunopathologyInternal MedicineHumansMedicineChildChromatography High Pressure LiquidUltrasonographyGlycated HemoglobinAnalysis of VarianceType 1 diabetesbusiness.industryPatient SelectionInsulinPubertymedicine.diseaseAdolescenceQuantitative ultrasoundDiabetes Mellitus Type 1EndocrinologyType 1 diabetesMetabolic control analysisFemaleAnalysis of variancebusinessQuantitative ultrasoundDiabetologia
researchProduct

Cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1H-dihydropyrrolizine type

2003

A series of 6,7-diaryl-2,3-1H-dihydropyrrolizines was prepared as COX-1/COX-2 and 5-LOX inhibitors. The inhibition of COX-1 was evaluated using intact bovine platelets as the enzyme source, whereas LPS-stimulated human monocytes served as the enzyme source for inducible COX-2. The determination of arachidonic metabolites was performed by HPLC for COX-1 and RIA for COX-2. The balance between COX-1/COX-2 and 5-LOX inhibition can be shifted by modifying the substitution pattern of the phenyl moiety at the 6- and 7-position of the pyrrolizine nucleus. Structure-activity relationships are discussed.

Blood PlateletsRadioimmunoassayHigh-performance liquid chromatographyIsozymeMonocytesDrug DiscoverymedicineCox 1 cox 2AnimalsHumansMoietyStructure–activity relationshipPyrrolesPlateletLipoxygenase InhibitorsEnzyme InhibitorsChromatography High Pressure LiquidPharmacologychemistry.chemical_classificationbiologyChemistryOrganic ChemistryMembrane ProteinsGeneral MedicineIn vitroIsoenzymesmedicine.anatomical_structureEnzymeBiochemistryCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesEnzyme inhibitorDrug DesignArachidonate 5-lipoxygenaseCyclooxygenase 1biology.proteinCattleCyclooxygenaseNucleusEuropean Journal of Medicinal Chemistry
researchProduct

Pharmacokinetics of acute and sub-chronic aripiprazole in P-glycoprotein deficient mice

2010

Abstract Background P-glycoprotein (P-gp), an efflux transporter localized in the blood–brain barrier, limits the access of multiple xenobiotics to the central nervous system (CNS). For the new antipsychotic aripiprazole and its active metabolite dehydroaripiprazole differences in disposition in blood and brain were investigated after acute and sub-chronic administration in a P-gp knockout mouse model. Methods Serum and brain concentrations of both drugs were measured at several time points 1–24 h after i.p. injection of 10 mg/kg aripiprazole and after 11 days of sub-chronic administration in several tissues. Moreover, the expression of P-gp was determined by Western blot analysis after sub…

Blotting WesternCentral nervous systemAripiprazoleQuinolonesPharmacologyBlood–brain barrierMass SpectrometryPiperazinesMiceCellular and Molecular NeurosciencePharmacokineticsmedicineAnimalsATP Binding Cassette Transporter Subfamily B Member 1Chromatography High Pressure LiquidActive metaboliteP-glycoproteinMice KnockoutPharmacologyAnalysis of VariancebiologyChemistryBrainBiological TransportTransportermedicine.anatomical_structureBlood-Brain BarrierKnockout mousebiology.proteinAripiprazoleAntipsychotic Agentsmedicine.drugNeuropharmacology
researchProduct

In-vitro test system for the evaluation of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibitors based on a single HPLC run with UV detect…

2001

Objective and Design: The aim of this study was to develop a new, whole-cell test system which is easy to handle and requires a standard equipment for the parallel screening of COX-1 and COX-2 inhibitors.¶Materials: Bovine aortic endothelial cells (BAECs).¶Treatment and methods: Unstimulated bovine aortic coronary endothelial cells (BAECs) were used as a source of COX-1 and BAECs pretreated with ASA (100 μM) and activated with phorbol myristate acetate (PMA) were used as a source of COX-2. The time- and concentration-dependent induction of COX-2 expression in the BAECs was evaluated by a kinetic profile (HPLC analysis) and detected by Western-Blot analysis using polyclonal antibodies agains…

Blotting WesternImmunologyDrug Evaluation PreclinicalAorta ThoracicIn Vitro TechniquesHigh-performance liquid chromatographyLipoxygenaseDiclofenacmedicineAnimalsCyclooxygenase InhibitorsLipoxygenase InhibitorsIC50Chromatography High Pressure LiquidPharmacologyCyclooxygenase 2 InhibitorsbiologyChemistryMolecular biologyIsoenzymesKineticsMeloxicamBiochemistryCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesPolyclonal antibodiesCyclooxygenase 1biology.proteinTetradecanoylphorbol AcetateAceclofenacCattleSpectrophotometry UltravioletEndothelium VascularCyclooxygenasemedicine.drugInflammation Research
researchProduct

Vertical ductile thinning and its contribution to the exhumation of high-pressure rocks: the Cycladic blueschist unit in the Aegean

2008

The contribution of vertical ductile thinning to the exhumation of high-pressure rocks is evaluated by estimating finite strain in 75 exhumed high-pressure rocks of the Cycladic blueschist unit in the Aegean Sea, Greece, and western Turkey. Strain data indicate heterogeneous deformation; principal stretches are 1.24–5.03 for S X , 0.63–2.53 for S Y and 0.10–0.81 for S Z , with a tensor average of S X : S Y : S Z =1.52:1.28:0.51. A 1D numerical model, which integrates velocity gradients along a vertical flow path with a steady-state orogen, is used to estimate the contribution of ductile thinning of the overburden of the high-pressure rocks to exhumation. Using a strain-rate law that is prop…

BlueschistOverburdenThinningFinite strain theoryHigh pressureFlow (psychology)Vertical flowGeologyDeformation (engineering)PetrologyGeologyJournal of the Geological Society
researchProduct

Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats

2011

Mildronate (3-(2,2,2-trimethylhydrazinium) propionate) is an inhibitor of l-carnitine biosynthesis and an anti-ischemic drug. In the present study, we investigated the effects of mildronate in rats following focal cerebral ischemia. Male Wistar rats were subjected to transient occlusion of the middle cerebral artery (MCAO) for 90min, followed by the intraperitoneal administration of mildronate at doses of 100 and 200mg/kg 2h after reperfusion and then daily for an additional 14days. The beam-walking, rota-rod and cylinder tests were used to assess sensorimotor function, and vibrissae-evoked forelimb-placing and limb-placing tests examined responses to tactile and proprioceptive stimulation.…

Brain InfarctionMaleIschemiaStimulationPharmacologyRotarod performance testBrain ischemiaBehavioral NeuroscienceAdjuvants ImmunologicTandem Mass SpectrometryCarnitinemedicine.arterymedicineAnimalsRats WistarStrokeChromatography High Pressure LiquidAnalysis of VarianceDose-Response Relationship Drugbusiness.industryExtremitiesInfarction Middle Cerebral ArteryRecovery of Functionmedicine.diseaseRatsBetaineDose–response relationshipRotarod Performance TestVibrissaeMiddle cerebral arterySystemic administrationbusinessNeuroscienceLocomotionPsychomotor PerformanceMethylhydrazinesBehavioural Brain Research
researchProduct